Clinical Trial Update: 6R-BH4 Pulmonary Arterial Hypertension Study [Phase 1]

View source ↗

Summary

An early Phase 1 study evaluating 6R-BH4 for pulmonary arterial hypertension has completed. The trial was conducted at Vanderbilt University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• 6R-BH4 (6R-tetrahydrobiopterin)

Snippet

Sponsor: Vanderbilt University | Conditions: Pulmonary Arterial Hypertension | Phase 1 | Status: COMPLETED